Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACCURAY INCARAY · Entity 1170 | Director · CEO | September 29, 2021 | November 02, 2021 |
| EDAP TMS SAEDAP · Entity 6325 | Director | August 14, 2026 | August 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACCURAY INC
Report date September 29, 2021 · Filed November 02, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,589,482 |
Ending reported balance
After 2021-09-29 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-09-29 · Grant · Acquired 250,501 · Balance 1,338,981 F1: This represents a Restricted Stock Unit grant on 10/29/21 that vest 1/3 annually over 3 years from grant date subject to continuous employment. Row 2 · 2021-09-29 · Grant · Acquired 250,501 · Balance 1,589,482 F2: This represents a Performance Stock Unit grant on 10/29/21 with a performance end-date of 06/30/2024. The maximum payout potential is 150% and subject to continuous employment. The metrics weighting consisting of 75% company revenue and 25% EBIDTA Margin. |
Filing footnotes · ownership attribution and instrument terms
F1: This represents a Restricted Stock Unit grant on 10/29/21 that vest 1/3 annually over 3 years from grant date subject to continuous employment.
F2: This represents a Performance Stock Unit grant on 10/29/21 with a performance end-date of 06/30/2024. The maximum payout potential is 150% and subject to continuous employment. The metrics weighting consisting of 75% company revenue and 25% EBIDTA Margin.
EDAP TMS SA
Report date August 14, 2026 · Filed August 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 45,000 |
Reported balance
After 2026-08-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-14 · Purchase · Acquired 10,000 · Balance 45,000 F1: Common Stock for the issuer refers to the issuer's ordinary shares. F2: The reported securities represent ordinary shares purchased by the reporting person in connection with an underwritten public offering of American Depositary Shares, each of which represents one ordinary share of the issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Common Stock for the issuer refers to the issuer's ordinary shares.
F2: The reported securities represent ordinary shares purchased by the reporting person in connection with an underwritten public offering of American Depositary Shares, each of which represents one ordinary share of the issuer.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NATUS MEDICAL INC
Report date July 21, 2022 · Filed July 21, 2022
Section 16 reporting ended · disclosed 2022-07-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.001 par value per shareSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-07-21 transaction · row 1
1 source rowRow 1 · 2022-07-21 · Disposition to issuer · Disposed 37,387 · Balance 0 F1: Disposed of pursuant to the previously announced Agreement and Plan of Merger, dated April 17, 2022, between Prince Parent Inc, Prince Mergerco Inc. and Issuer ("Merger Agreement"). F2: Each share of Common Stock was cancelled pursuant to the Merger Agreement in exchange for the right to receive the cash consideration provided in the Merger Agreement, subject to the applicable tax withholding. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the previously announced Agreement and Plan of Merger, dated April 17, 2022, between Prince Parent Inc, Prince Mergerco Inc. and Issuer ("Merger Agreement").
F2: Each share of Common Stock was cancelled pursuant to the Merger Agreement in exchange for the right to receive the cash consideration provided in the Merger Agreement, subject to the applicable tax withholding.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 14, 2026 Filed Aug 17, 2026 10:04 UTC | EDAP TMS SA EDAP · Entity 6325 | PurchaseCommon Stock | 10,000 | $4.75 | $47,500.00 |
DisclosureSEC source: 0001829126-26-008925 · ownership.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 F1 · security: Common Stock for the issuer refers to the issuer's ordinary shares. F2 · security: The reported securities represent ordinary shares purchased by the reporting person in connection with an underwritten public offering of American Depositary Shares, each of which represents one ordinary share of the issuer. Read SEC document |
| May 11, 2026 Filed May 13, 2026 10:03 UTC | EDAP TMS SA EDAP · Entity 6325 | PurchaseCommon Stock | 10,000 | $4.22 | $42,200.00 |
DisclosureSEC source: 0001829126-26-005043 · ownership.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 F1 · security: Common Stock for the issuer refers to the issuer's ordinary shares. Read SEC document |
| July 21, 2022 Filed Jul 21, 2022 17:20 UTC | NATUS MEDICAL INC NTUS · Entity 125256 | Disposition to issuerCommon Stock, $0.001 par value per share | 37,387 | $33.50 | $1,252,464.50 |
DisclosureSEC source: 0000878526-22-000098 · wf-form4_165843841066601.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Disposed of pursuant to the previously announced Agreement and Plan of Merger, dated April 17, 2022, between Prince Parent Inc, Prince Mergerco Inc. and Issuer ("Merger Agreement"). F2 · price: Each share of Common Stock was cancelled pursuant to the Merger Agreement in exchange for the right to receive the cash consideration provided in the Merger Agreement, subject to the applicable tax withholding. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 16:53 UTC | NATUS MEDICAL INC NTUS · Entity 125256 | GrantCommon Stock, $0.001 par value per share | 5,075 | $0.00 | $0.00 |
DisclosureSEC source: 0000878526-22-000047 · wf-form4_165549919769312.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,387 F1 · shares: The shares vest in full on the first anniversary of the date of the award. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 21:20 UTC | ACCURAY INC ARAY · Entity 1170 | SaleCommon Stock | 15,741 | $3.96 | $62,334.36 |
DisclosureSEC source: 0001214659-21-010202 · marketforms-53957.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,088,480 F1 · shares: This represents shares sold to cover the tax obligation for a Restricted Stock Unit vesting. Read SEC document |
| September 30, 2021 Filed Oct 13, 2021 01:59 UTC Amendment | ACCURAY INC ARAY · Entity 1170 | SaleCommon Stock | 15,741 | $3.96 | $62,334.36 |
DisclosureSEC source: 0001214659-21-010427 · marketforms-54000.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,088,480 F2 · shares: The Reporting Person realized short-swing profits under Section 16(b) of the Securities Exchange Act of 1934, as amended, as a result of sales of the Issuer's common stock reported herein being matched against previous purchases of the Issuer's common stock by the Reporting Person made in August 2021. The Reporting Person has agreed to voluntarily disgorge to the Issuer all short-swing profits realized by the Reporting Person from such transaction. F1 · price: This represents shares sold to cover the tax obligation for a Restricted Stock Unit vesting. Read SEC document |
| September 29, 2021 Filed Nov 2, 2021 20:03 UTC | ACCURAY INC ARAY · Entity 1170 | GrantCommon Stock | 250,501 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-21-011053 · marketforms-54133.xml · nonDerivative · entry 2 LEVINE JOSHUA · CIK 0001159917 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,589,482 F2 · shares: This represents a Performance Stock Unit grant on 10/29/21 with a performance end-date of 06/30/2024. The maximum payout potential is 150% and subject to continuous employment. The metrics weighting consisting of 75% company revenue and 25% EBIDTA Margin. Read SEC document |
| September 29, 2021 Filed Nov 2, 2021 20:03 UTC | ACCURAY INC ARAY · Entity 1170 | GrantCommon Stock | 250,501 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-21-011053 · marketforms-54133.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,338,981 F1 · shares: This represents a Restricted Stock Unit grant on 10/29/21 that vest 1/3 annually over 3 years from grant date subject to continuous employment. Read SEC document |
| August 18, 2021 Filed Aug 19, 2021 20:25 UTC | ACCURAY INC ARAY · Entity 1170 | PurchaseCommon Stock | 6,320 | $3.62 | $22,878.40 |
DisclosureSEC source: 0001214659-21-008821 · marketforms-53621.xml · nonDerivative · entry 2 LEVINE JOSHUA · CIK 0001159917 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,104,221 Read SEC document |
| August 18, 2021 Filed Aug 19, 2021 20:25 UTC | ACCURAY INC ARAY · Entity 1170 | PurchaseCommon Stock | 8,680 | $3.63 | $31,508.40 |
DisclosureSEC source: 0001214659-21-008821 · marketforms-53621.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,097,901 Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 17:09 UTC | NATUS MEDICAL INC NTUS · Entity 125256 | GrantCommon Stock, $0.001 par value per share | 5,214 | $28.77 | $150,006.78 |
DisclosureSEC source: 0000878526-21-000067 · wf-form4_162430973969804.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,312 F1 · shares: The shares vest in full on the first anniversary of the date of the award. Read SEC document |
| December 28, 2020 Filed Dec 29, 2020 21:10 UTC | ACCURAY INC ARAY · Entity 1170 | OtherCommon Stock | 42,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-010732 · marketforms-50773.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 987,497 F1 · kind: Represents shares transferred pursuant to divorce settlement. Read SEC document |
| December 02, 2020 Filed Dec 3, 2020 02:41 UTC | ACCURAY INC ARAY · Entity 1170 | SaleCommon Stock | 15,674 | $4.07 | $63,804.15 |
DisclosureSEC source: 0001138723-20-000113 · edgardoc.xml · nonDerivative · entry 2 LEVINE JOSHUA · CIK 0001159917 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,029,538 F2 · shares: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States. Read SEC document |
| November 30, 2020 Filed Dec 3, 2020 02:41 UTC | ACCURAY INC ARAY · Entity 1170 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 527,426 | $0.00 Strike: $4.46 | $0.00 |
DisclosureSEC source: 0001138723-20-000113 · edgardoc.xml · derivative · entry 3 LEVINE JOSHUA · CIK 0001159917 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 527,426 Underlying: Common Stock · 527,426 shares Expires 2030-11-30 F3 · derivative.exercise_date: 25% of the shares subject to such Option shall vest and be exercisable on the one-year anniversary of the Grant Date and an additional 1/48th of the original number of shares subject to such Option shall vest on the corresponding date of each month thereafter, subject to the applicable Grantee continuing to be a service provider through each such date. Read SEC document |
| November 30, 2020 Filed Dec 3, 2020 02:41 UTC | ACCURAY INC ARAY · Entity 1170 | GrantCommon Stock | 280,269 | $0.00 | $0.00 |
DisclosureSEC source: 0001138723-20-000113 · edgardoc.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,045,212 F1 · shares: Fiscal year 2021 Performance award with two Performance Measurement Periods The first represents 40% of the grant and is from 7/1/2020 to 6/30/2021. The second represents 60% and is from 7/1/2021 to 06/30/2022. If the metrics are met for the first performance period vesting will commence quarterly beginning 9/30/2021 and ending 06/30/2023. If the metrics are met for the second performance period vesting will commence quarterly beginning 09/30/2022 and ending 06/30/2023. Read SEC document |
| October 02, 2020 Filed Oct 7, 2020 01:25 UTC | ACCURAY INC ARAY · Entity 1170 | SaleCommon Stock | 15,370 | $2.43 | $37,366.01 |
DisclosureSEC source: 0001138723-20-000043 · edgardoc.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 764,943 F1 · shares: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States. F2 · balance_after: Beneficially owned shares reduced by 418,490 shares cancelled from 10/31/2019 performance grant and 133,500 shares cancelled shares from 09/29/2017 performance grant where the performance metrics were not met. Read SEC document |
| June 19, 2020 Filed Jun 22, 2020 17:07 UTC | NATUS MEDICAL INC NTUS · Entity 125256 | GrantCommon Stock, $0.001 par vale per share | 7,120 | $21.07 | $150,018.40 |
DisclosureSEC source: 0000878526-20-000061 · wf-form4_159286003253601.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,098 F1 · shares: The shares vest in full on the first anniversary of the date of the award. Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 21:10 UTC | ACCURAY INC ARAY · Entity 1170 | SaleCommon Stock | 17,587 | $2.74 | $48,207.73 |
DisclosureSEC source: 0001138723-19-000076 · edgardoc.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,331,966 F1 · shares: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States. Read SEC document |
| October 31, 2019 Filed Nov 4, 2019 21:25 UTC | ACCURAY INC ARAY · Entity 1170 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 923,020 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001138723-19-000046 · edgardoc.xml · derivative · entry 3 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 923,020 Underlying: Common Stock · 923,020 shares Expires 2029-10-31 F3 · derivative.exercise_date: The options are exercisable as they vest. A total of 25% of the entire number of shares subject to this stock option becomes vested and fully exercisable on the first anniversary of the vesting commencement date and the remaining shares subject to this stock option vest and become exercisable in equal monthly installments, ratably over the following 36 months. Read SEC document |
| October 31, 2019 Filed Nov 4, 2019 21:25 UTC | ACCURAY INC ARAY · Entity 1170 | GrantCommon Stock | 418,490 | $0.00 | $0.00 |
DisclosureSEC source: 0001138723-19-000046 · edgardoc.xml · nonDerivative · entry 2 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,349,553 F2 · shares: Fiscal year 2020 Performance award with Performance Measurement Period from 7/1/2019 to 6/30/2020. If the performance metrics are met the vesting will occur on the last day of the quarter for two years beginning 9/30/2020 contingent on continued employment. Read SEC document |
| October 31, 2019 Filed Nov 4, 2019 21:25 UTC | ACCURAY INC ARAY · Entity 1170 | SaleCommon Stock | 28,081 | $2.61 | $73,313.87 |
DisclosureSEC source: 0001138723-19-000046 · edgardoc.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 931,063 F1 · shares: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 21:12 UTC | ACCURAY INC ARAY · Entity 1170 | SaleCommon Stock | 18,023 | $2.72 | $49,031.57 |
DisclosureSEC source: 0001138723-19-000028 · edgardoc.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 959,144 F1 · kind: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States. Read SEC document |
| July 02, 2019 Filed Jul 5, 2019 21:59 UTC | ACCURAY INC ARAY · Entity 1170 | SaleCommon Stock | 56,426 | $3.75 | $211,631.36 |
DisclosureSEC source: 0001138723-19-000016 · edgardoc.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 977,167 F1 · kind: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 17:12 UTC | NATUS MEDICAL INC BABY · Entity 125256 | GrantCommon Stock, $0.001 par vale per share | 5,846 | $25.66 | $150,008.36 |
DisclosureSEC source: 0000878526-19-000096 · wf-form4_156210195968204.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,978 F1 · shares: The shares vest in full on the first anniversary of the date of the award. Read SEC document |
| April 02, 2019 Filed Apr 3, 2019 20:59 UTC | ACCURAY INC ARAY · Entity 1170 | SaleCommon Stock | 6,604 | $4.54 | $29,982.16 |
DisclosureSEC source: 0001138723-19-000004 · edgardoc.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,033,593 F1 · shares: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States. Read SEC document |
| January 29, 2019 Filed Jan 31, 2019 23:39 UTC | ACCURAY INC ARAY · Entity 1170 | OtherCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001138723-19-000002 · edgardoc.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,040,197 F1 · shares: Mr. Levine transferred 300,000 shares of Accuray Inc. common stock to his ex-wife pursuant to a divorce settlement. Read SEC document |
| December 03, 2018 Filed Dec 7, 2018 00:57 UTC | ACCURAY INC ARAY · Entity 1170 | SaleCommon Stock | 15,839 | $4.00 | $63,344.91 |
DisclosureSEC source: 0001138723-18-000115 · edgardoc.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,340,197 F1 · shares: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States. Read SEC document |
| November 30, 2018 Filed Dec 7, 2018 00:57 UTC | ACCURAY INC ARAY · Entity 1170 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 1,625,000 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001138723-18-000115 · edgardoc.xml · derivative · entry 2 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,625,000 Underlying: Common Stock · 1,625,000 shares Expires 2028-11-30 F2 · derivative.exercise_date: The options are exercisable as they vest. A total of 25% of the entire number of shares subject to this stock option becomes vested and fully exercisable on the first anniversary of the vesting commencement date and the remaining shares subject to this stock option vest and become exercisable in equal monthly installments, ratably over the following 36 months. Read SEC document |
| November 05, 2018 Filed Nov 6, 2018 21:58 UTC | ACCURAY INC ARAY · Entity 1170 | PurchaseCommon Stock | 25,000 | $4.75 | $118,750.00 |
DisclosureSEC source: 0001138723-18-000075 · edgardoc.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,356,036 F1 · shares: The purchase price represents the weighted average purchase price within a range of $1. Upon request by the Commission Staff, the Issuer or Security Holder, the Reporting Person will provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 01, 2018 Filed Nov 2, 2018 20:06 UTC | ACCURAY INC ARAY · Entity 1170 | SaleCommon Stock | 24,515 | $4.63 | $113,617.22 |
DisclosureSEC source: 0001138723-18-000072 · edgardoc.xml · nonDerivative · entry 2 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,331,036 F1 · shares: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States. Read SEC document |
| October 31, 2018 Filed Nov 2, 2018 20:06 UTC | ACCURAY INC ARAY · Entity 1170 | SaleCommon Stock | 18,742 | $4.69 | $87,903.73 |
DisclosureSEC source: 0001138723-18-000072 · edgardoc.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,355,551 F1 · shares: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States. Read SEC document |
| October 03, 2018 Filed Oct 4, 2018 21:07 UTC | ACCURAY INC ARAY · Entity 1170 | SaleCommon Stock | 12,869 | $4.38 | $56,404.83 |
DisclosureSEC source: 0001138723-18-000056 · edgardoc.xml · nonDerivative · entry 2 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,374,293 F1 · kind: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States. Read SEC document |
| October 02, 2018 Filed Oct 4, 2018 21:07 UTC | ACCURAY INC ARAY · Entity 1170 | SaleCommon Stock | 4,373 | $4.39 | $19,197.91 |
DisclosureSEC source: 0001138723-18-000056 · edgardoc.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,387,162 F1 · kind: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States. Read SEC document |
| July 03, 2018 Filed Jul 3, 2018 22:44 UTC | ACCURAY INC ARAY · Entity 1170 | SaleCommon Stock | 34,235 | $4.08 | $139,507.63 |
DisclosureSEC source: 0001138723-18-000023 · edgardoc.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,392,518 F1 · shares: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States. Read SEC document |
| July 03, 2018 Filed Jul 7, 2018 00:53 UTC Amendment | ACCURAY INC ARAY · Entity 1170 | SaleCommon Stock | 8,218 | $4.09 | $33,598.47 |
DisclosureSEC source: 0001138723-18-000033 · edgardoc.xml · nonDerivative · entry 2 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,391,535 F1 · shares: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States. F3 · price: This transaction was executed in multiple trades during the day at prices ranging from $4.0500 to $4.1000. The weighted-average price is reported above. Read SEC document |
| July 03, 2018 Filed Jul 7, 2018 00:53 UTC Amendment | ACCURAY INC ARAY · Entity 1170 | SaleCommon Stock | 27,000 | $4.05 | $109,352.70 |
DisclosureSEC source: 0001138723-18-000033 · edgardoc.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,399,753 F1 · shares: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States. F2 · price: This transaction was executed in multiple trades during the day at prices ranging from $4.0500 to $4.0750. The weighted-average price is reported above. Read SEC document |
| April 03, 2018 Filed Apr 3, 2018 22:04 UTC | ACCURAY INC ARAY · Entity 1170 | SaleCommon Stock | 8,675 | $4.65 | $40,338.75 |
DisclosureSEC source: 0001138723-18-000010 · edgardoc.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,426,753 F1 · shares: Shares were automatically sold into the open market in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States. Read SEC document |
| December 01, 2017 Filed Dec 1, 2017 23:07 UTC | ACCURAY INC ARAY · Entity 1170 | SaleCommon Stock | 17,093 | $4.86 | $83,013.86 |
DisclosureSEC source: 0001138723-17-000064 · edgardoc.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,435,428 F1 · shares: Shares were automatically sold into the open market in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States. Read SEC document |
| November 01, 2017 Filed Nov 1, 2017 23:49 UTC | ACCURAY INC ARAY · Entity 1170 | Tax withholdingCommon Stock | 28,946 | $4.31 | $124,760.15 |
DisclosureSEC source: 0001138723-17-000044 · edgardoc.xml · nonDerivative · entry 3 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,452,521 F1 · shares: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States. Read SEC document |
| November 01, 2017 Filed Nov 1, 2017 23:49 UTC | ACCURAY INC ARAY · Entity 1170 | Tax withholdingCommon Stock | 21,710 | $4.31 | $93,611.35 |
DisclosureSEC source: 0001138723-17-000044 · edgardoc.xml · nonDerivative · entry 2 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,481,467 F1 · shares: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States. Read SEC document |
| October 31, 2017 Filed Nov 1, 2017 23:49 UTC | ACCURAY INC ARAY · Entity 1170 | Tax withholdingCommon Stock | 27,117 | $4.55 | $123,436.58 |
DisclosureSEC source: 0001138723-17-000044 · edgardoc.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,503,177 F1 · shares: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States. Read SEC document |
| September 29, 2017 Filed Oct 4, 2017 23:51 UTC | ACCURAY INC ARAY · Entity 1170 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 312,000 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001138723-17-000032 · edgardoc.xml · derivative · entry 2 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,000 Underlying: Common Stock · 312,000 shares Expires 2027-09-29 F2 · derivative.exercise_date: The options are exercisable as they vest. A total of 25% of the entire number of shares subject to this stock option becomes vested and fully exercisable on the first anniversary of the vesting commencement date and the remaining shares subject to this stock option vest and become exercisable in equal monthly installments, ratably over the following 36 months. Read SEC document |
| September 29, 2017 Filed Oct 4, 2017 23:51 UTC | ACCURAY INC ARAY · Entity 1170 | GrantCommon Stock | 133,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001138723-17-000032 · edgardoc.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,530,294 F1 · shares: The restricted stock units (RSUs) are released as they vest. A total of 25% of the shares subject to this grant become vested and are released on the first anniversary of the vesting commencement date and the remaining shares vest and are released at a rate of 25% a year on each anniversary of the vesting commencement date over the remaining three years. Read SEC document |
| June 30, 2017 Filed Jul 3, 2017 19:37 UTC | ACCURAY INC ARAY · Entity 1170 | Tax withholdingCommon Stock | 37,205 | $4.75 | $176,723.75 |
DisclosureSEC source: 0001138723-17-000018 · edgardoc.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,397,294 F1 · shares: Represents shares of Common Stock that were withheld by the issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of RSUs. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:52 UTC | ACCURAY INC ARAY · Entity 1170 | Tax withholdingCommon Stock | 9,691 | $4.70 | $45,547.70 |
DisclosureSEC source: 0001138723-17-000006 · edgardoc.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,434,499 Read SEC document |
| December 01, 2016 Filed Dec 2, 2016 23:23 UTC | ACCURAY INC ARAY · Entity 1170 | Tax withholdingCommon Stock | 26,820 | $5.06 | $135,634.10 |
DisclosureSEC source: 0001138723-16-000138 · edgardoc.xml · nonDerivative · entry 2 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,444,190 F2 · price: A total of 26,820 shares were sold pursuant to a 10b5-1 Plan, at an average sale price of $5.057205 per share. The actual sale price for the shares was: 7,730 shares at $5.075 and 19,090 shares at $5.05. Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 23:23 UTC | ACCURAY INC ARAY · Entity 1170 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 306,900 | $0.00 Strike: $5.05 | $0.00 |
DisclosureSEC source: 0001138723-16-000138 · edgardoc.xml · derivative · entry 3 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,900 Underlying: Common Stock · 306,900 shares Expires 2026-11-30 F3 · derivative.exercise_date: The options are exercisable as they vest. A total of 25% of the entire number of shares subject to this stock option becomes vested and fully exercisable on the first anniversary of the vesting commencement date and the remaining shares subject to this stock option vest and become exercisable in equal monthly installments, ratably over the following 36 months. Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 23:23 UTC | ACCURAY INC ARAY · Entity 1170 | GrantCommon Stock | 122,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001138723-16-000138 · edgardoc.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,471,010 F1 · shares: The restricted stock units (RSUs) are released as they vest. A total of 25% of the shares subject to this grant become vested and are released on the first anniversary of the vesting commencement date and the remaining shares vest and are released at a rate of 25% a year on each anniversary of the vesting commencement date over the remaining three years. Read SEC document |
| November 01, 2016 Filed Nov 2, 2016 21:54 UTC | ACCURAY INC ARAY · Entity 1170 | Tax withholdingCommon Stock | 74,506 | $4.85 | $361,145.48 |
DisclosureSEC source: 0001138723-16-000118 · edgardoc.xml · nonDerivative · entry 1 LEVINE JOSHUA · CIK 0001159917 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,348,210 F1 · price: A total of 74,506 shares were sold pursuant to a 10b5-1 Plan, at an average sale price of $4.84717 per share. The actual sale price for the shares was: 600 shares at $4.925; 500 shares at $4.90; 1,300 shares at $4.8625; 5,381 shares at $4.875; 700 shares at $4.80; 50,161 shares at $4.85; and 15,864 shares at $4.825. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.